trending Market Intelligence /marketintelligence/en/news-insights/trending/cigqeonk4mzdyd3qvuxrsq2 content esgSubNav
In This List

Onconova granted time to regain compliance with Nasdaq

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Onconova granted time to regain compliance with Nasdaq

The Nasdaq granted Onconova Therapeutics Inc. time to regain compliance with the exchange's minimum stockholders' equity requirement of $2.5 million.

The Newtown, Pa.-based biotechnology company developing treatments for cancer has until April 13 to regain compliance.